T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients

Stanley R. Riddell(Fred Hutch Cancer Center), Mark Elliott(Fred Hutch Cancer Center), Deborah A. Lewinsohn(Fred Hutch Cancer Center), M. Jean Gilbert(University of Washington), L.A. Wilson(Target (United States)), Sara A. Manley(Target (United States)), Stephen D. Lupton(Target (United States)), Robert W. Overell(Target (United States)), Thomas C. Reynolds(Target (United States)), Lawrence Corey(University of Washington), Philip D. Greenberg(University of Washington)

Nature Medicine

February 1, 1996

10.1038/nm0296-216

Cited by 575

Abstract

Related Papers

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

Richard A. Koup, Jeffrey T. Safrit, Yaming Cao et al.|Journal of Virology|1994|2.5k

Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones

Stanley R. Riddell, Käthe S. Watanabe, J. M. Goodrich et al.|Science|1992|1.2k

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

Lieping Chen, Stephanie Ashe, William Brady et al.|Cell|1992|1.1k

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

Ronald G. Crystal, Noel G. McElvaney, Melissa A. Rosenfeld et al.|Nature Genetics|1994|828

Herpes simplex virus turns off the TAP to evade host immunity

Ann B. Hill, Pieter Jugovic, lan York et al.|Nature|1995|798